Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Credit agrmnt [a]
Acq. announced
Quarterly results
CC transcript

TALBOTS INC (TLB) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/16/2018 GN TearLab Corporation Announces Voluntary Delisting From Toronto Stock Exchange
03/02/2018 GN TearLab Corporation Reports Fourth Quarter and Full Year 2017 Financial Results
02/28/2018 GN TearLab Osmolarity System Launches in Brazil
02/14/2018 GN TearLab Provides Updates on Its Osmolarity Test and TearLab Discovery™ Platform
01/04/2018 GN TearLab Submits 510(k) for U.S. FDA Clearance of TearLab Discovery™ Platform
12/06/2017 GN TearLab Prices $3.0 Million Registered Direct Offering
11/30/2017 GN TearLab Launches Registered Direct Offering
11/13/2017 GN TearLab Corporation Reports Third Quarter and September Year-To-Date 2017 Financial Results
11/09/2017 GN TearLab Corporation Begins Trading on OTCQB
11/01/2017 GN TearLab Corporation to Release Third Quarter 2017 Financial Results on November 13, 2017
10/17/2017 GN TearLab Corporation Provides Update on U.S. Regulatory Strategy for TearLab Discovery™ System
09/27/2017 GN TearLab Corporation Announces Release of 2018 - 2020 Preliminary Reimbursement Rates
08/30/2017 GN TearLab Receives Nasdaq Listing Extension
08/14/2017 GN TearLab Corporation Reports Second Quarter and First Half 2017 Financial Results
07/21/2017 GN TearLab Announces European Regulatory Clearance for Next-Generation TearLab Discovery™ System
06/21/2017 GN TearLab Receives Nasdaq Listing Extension
05/15/2017 GN TearLab Corporation Reports First Quarter 2017 Financial Results
05/12/2017 GN TearLab Osmolarity System Receives Brazilian Regulatory Approval
05/12/2017 GN TearLab Osmolarity System Receives Brazilian Regulatory Approval
05/01/2017 GN TearLab Corporation to Release First Quarter 2017 Financial Results on May 15, 2017
03/06/2017 GN TearLab Announces CE Marking for Next-Generation System
03/06/2017 GN TearLab Announces CE Marking for Next-Generation System
02/24/2017 GN TearLab Announces 1-for-10 Reverse Split of Common Stock
02/24/2017 GN TearLab Announces 1-for-10 Reverse Split of Common Stock
02/21/2017 GN TearLab Corporation to Report Fourth Quarter and Full-year 2016 Financial Results on March 9, 2017
02/13/2017 GN TearLab Provides Update on International Market Milestones
02/13/2017 GN TearLab Provides Update on International Market Milestones
08/20/2012 15-12B Form 15-12B - Securities registration termination [Section 12(b)]
08/14/2012 EFFECT Form EFFECT - Notice of Effectiveness
08/14/2012 EFFECT Form EFFECT - Notice of Effectiveness
08/07/2012 4 SULLIVAN TRUDY F (President & CEO) has filed a Form 4 on TALBOTS INC
Txns: Unknown transaction of 507,400 shares @ $2.75, valued at $1.4M
Disposed/sold 187,100 options to buy @ $2.36, valued at $441.6k
08/07/2012 4 SCARPA MICHAEL (COO, CFO and Treasurer) has filed a Form 4 on TALBOTS INC
Txns: Disposed/sold 75,000 options to buy @ $2, valued at $150k
Disposed/sold 131,250 options to buy @ $2.36, valued at $309.8k
08/07/2012 4 CASAMENTO BENEDETTA I (EVP, Finance) has filed a Form 4 on TALBOTS INC
Txns: Disposed/sold 85,226 shares @ $2.75, valued at $234.4k
08/07/2012 4 FITZGERALD DEIRDRE (EVP, Gen Merchandise Manager) has filed a Form 4 on TALBOTS INC
Txns: Unknown transaction of 16,699 shares @ $2.75, valued at $45.9k
Disposed/sold 8,500 options to buy @ $2.36, valued at $20.1k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy